Stephen J.Kovacic (Steve)

Associate

Cleveland + 1.216.586.1313

Connect

Share

Steve Kovacic represents public and private companies on corporate law matters. His practice focuses on representing clients in domestic and cross-border mergers, acquisitions, corporate restructurings, and other strategic transactions. His practice also includes counseling clients on corporate governance and other general corporate matters.

Erfahrung

  • ITT completes divestiture of Wolverine Advanced MaterialsJones Day advised ITT, Inc. in the $171 million sale of its Wolverine Advanced Materials business to private equity firm Center Rock Capital Partners.
  • STERIS sells dental segment to an affiliate of Peak Rock CapitalJones Day advised STERIS Plc in the $787.5 million sale of Dental segment to Peak Rock Capital, a leading middle-market private investment firm.
  • BioMarin announces governance enhancements and value creation initiativesJones Day advised the Board of Directors of BioMarin Pharmaceutical Inc. ("BioMarin") in connection with its entry into a Cooperation Agreement and an Information Sharing Agreement with activist shareholder Elliott Management.
  • Flottec sold to Nalco WaterJones Day represented Flottec, LLC, a company focused on the development of advanced flotation technology and the supply of flotation reagents and mineral processing chemicals, in connection with its sale to Nalco Company LLC, an Illinois-based supplier of water, energy and air improvement solutions and services for industrial markets and Ecolab Inc. company.
  • Timken acquires Des-CaseJones Day advised The Timken Company in the acquisition of Des-Case Corp., a Nashville, Tenn.-based manufacturer of specialty filtration products for industrial lubricants.
  • Timken acquires Nadella Group from ICGJones Day advised The Timken Company in the acquisition of Nadella Group, a leading European manufacturer of linear guides, telescopic rails, actuators and systems and other specialized industrial motion solutions, from ICG plc.
  • Timken acquires GGB Bearing Technology for $305 millionJones Day advised The Timken Company in the $305 million acquisition of GGB Bearing Technology (GGB), a division of Enpro, Industries (including exclusive negotiations with respect to the French operations of GGB).
  • Nordson Corporation acquires CyberOptics CorporationJones Day advised Nordson Corporation in the acquisition of CyberOptics Corporation, a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions.
  • Avient divests distribution business to H.I.G. CapitalJones Day advised Avient Corporation in the $950 million sale of its Distribution business to an affiliate of H.I.G. Capital.
  • Global Risk Capital acquires legacy asbestos and environmental liabilities from SPXJones Day advised Global Risk Capital and its joint venture with partner Premia Holdings Ltd. in their acquisition from SPX Technologies, Inc. of SPX, LLC, which is a legacy SPX company that primarily holds liabilities, including asbestos and environmental liabilities and related insurance assets.
  • Marubeni sells global grain business of Gavilon Agriculture InvestmentJones Day advised Marubeni Corporation in the sale of the global grain business of Gavilon Agriculture Investment, Inc. to Viterra Limited, following a reorganization of Gavilon’s structure.
  • Avient acquires DSM Protective Materials businessJones Day advised Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable material solutions, in the $1.485 billion acquisition and financing of Koninklijke DSM N.V.’s protective materials business, a leading specialty engineered materials business built around the invention of Dyneema®, the world’s strongest fiber.
  • FirstEnergy sells $2.4 billion minority transmission stake to BrookfieldJones Day represented FirstEnergy Corp. in its $2.4 billion sale of a 19.9% equity stake in its subsidiary FirstEnergy Transmission, the holding company for FirstEnergy’s three regulated electric transmission businesses.
  • STERIS sells renal business to EvoquaJones Day advised STERIS in the $196.3 million sale of its Renal Care business to Evoqua Water Technologies, a leading provider of mission-critical water and wastewater treatment solutions.
  • Riverside portfolio company acquires milliCareJones Day represented The Riverside Company in connection with the acquisition by portfolio company Clintar of milliCare, a floor and textile care franchise brand, providing leading carpet, floor and textile care solutions.
  • Trustwave sells PCI compliance business to SysnetJones Day advised Trustwave in the $80 million sale of its payment card industry compliance business (SecureTrust and FLEX divisions) to Sysnet Global Solutions.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
  • KeyBanc Capital Markets-led syndicate completes $400 million Senior Notes offering by CTR Partnership, L.P. and CareTrust Capital Corp.Jones Day represented KeyBanc Capital Markets Inc., as representative of the several initial purchasers, in connection with the Rule 144A and Regulation S offering by CTR Partnership, L.P. and CareTrust Capital Corp. of $400 million aggregate principal amount of 3.875% Senior Notes due 2028.
  • Riverside portfolio company acquires DIGARCJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Modern Campus of DIGARC, the leading provider of academic catalog and curriculum management, class and student scheduling, and student pathfinder software for higher education.
  • Cooper Tire & Rubber sold to The Goodyear Tire & Rubber Company for approximately $2.5 billion enterprise valueJones Day advised Cooper Tire & Rubber Company in its $2.5 billion sale to The Goodyear Tire & Rubber Company.
    •

    Bitte beachten Sie vor dem Versenden:

    Die Informationen auf unserer Website sind für den allgemeinen Gebrauch und stellen keine Rechtsberatung dar. Der Versand dieser E-Mail ist nicht dazu bestimmt, ein Mandatsverhältnis zu begründen, und der Erhalt dieser E-Mail stellt kein Mandatsverhältnis dar. Alles, was Sie an jemanden in unserer Kanzlei senden, ist nicht vertraulich oder privilegiert, es sei denn, wir haben zugestimmt, Sie zu vertreten. Wenn Sie diese E-Mail versenden, bestätigen Sie, dass Sie diesen Hinweis gelesen und verstanden haben.